Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0038389992
Fri, 23.04.2021
BB BIOTECH AG
Media Release, April 23, 2021
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at March 31, 2021, which covers the results of its business activities for the first three months of 2021.
Based on the consolidated accounts of BB Biotech AG, net profit for the period ended March 31, 2 [ … ]
Fri, 22.01.2021
BB BIOTECH AG
Media release of January 22, 2021
BB Biotech AG closes the 2020 fiscal year with a profit
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information about its results for its fiscal year 2020.
Based on its preliminary unaudited consolidated figures, BB Biotech AG reports a profit [ … ]
Fri, 22.01.2021
BB BIOTECH AG
Media release as of January 22, 2021
Portfolio of BB Biotech AG as of December 31, 2020
Vaccines leading the way out of the pandemic - increased dividend of CHF 3.60 proposedBB Biotech performed well in 2020 in a volatile market environment. The biotech sector made significant strides, leading the effort against the SARS-CoV-2 virus pandemic thro [ … ]
Wed, 16.12.2020
BB BIOTECH AG
Media release of December 16, 2020
Market commentary
Moderna and its COVID-19 vaccine are representative of the innovative power of the entire biotech industryModerna, the US company about to launch an mRNA-based COVID-19 vaccine, is the latest shining example of the progress biotech companies are making for the good of society. In addition to th [ … ]
Fri, 23.10.2020
BB BIOTECH AG
Media release as at October 23, 2020
Interim report of BB Biotech AG as at September 30, 2020
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at September 30, 2020, which covers the results of its business activities for the first nine months of 2020.
Based on the consolidated a [ … ]
Fri, 23.10.2020
BB BIOTECH AG
Media release as at October 23, 2020
Interim report of BB Biotech AG as at September 30, 2020
Biotech M&A picks up in the third quarter of 2020 - BB Biotech delivers a pleasing 9-month performance
The Nasdaq biotechnology index consolidated in the third quarter (-0.8%) following a very strong second quarter. BB Biotech displayed a similar pa [ … ]